Tweenvest Stocks

Apogee Therapeutics, Inc. (NasdaqGM: APGE)

Health Care · Biotechnology · US

$—

— today · — 1Y

Apogee Therapeutics, Inc. (NasdaqGM: APGE) operates in the Biotechnology industry within the Health Care sector.

trading between 51.80 and 135.09.

Tweenvest scores Apogee Therapeutics, Inc. across four factors: quality 51/100, value 88/100. Its strongest factor is value.

APGE price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
—
P/E
—
EPS
-4.34
Dividend yield
—
Beta (5Y)
—
52-week high
$135.09
52-week low
$51.80
Avg volume (3M)
—
Shares outstanding
—
Employees
261
Next earnings
—

About Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.

ISIN
US03770N1019
Founded
2022
Listed since
Jul 14, 2023
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
PhaseRx, Inc.OTCPK: PZRX.Q$12.00$——
ContraFect CorporationOTCPK: CFRX.Q$11.00$0.00—
Notable Labs, Ltd.OTCPK: NTBL.Q$10.00$——
OncoSec Medical IncorporatedOTCPK: ONCS.Q$6.00$0.00—
Calithera Biosciences, Inc.OTCPK: CALA$5.00$0.00-99.00%
Biocept, Inc.OTCPK: BIOC.Q$3.00$0.00-99.50%
Yield10 Bioscience, Inc.OTCPK: YTEN.Q$1.00$——
LadRx CorporationOTCPK: LADX$0.00$0.00-99.50%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.